Skip to main content
Retour
Watch Compare

BIODESIX INC

Qualité des données : 100%
BDSX
Nasdaq Services Health Services
12,90 €
▼ 1,35 € (-9,47%)
Cap. Boursière: 127,17 M
Prix
12,90 €
Cap. Boursière
127,17 M
Fourchette du Jour
12,88 € — 14,37 €
Fourchette 52 Semaines
3,44 € — 20,21 €
Volume
36 703
Ouverture 14,07 €
Moyenne 50J / 200J
13,84 €
6,76% below
Moyenne 50J / 200J
9,04 €
42,69% above

Quick Summary

Points Clés

Revenue grew 12,88% annually over 5 years — strong growth
Negative free cash flow of -23,53 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 11,20%
Capital efficient — spends only 0,29% of revenue on capex

Croissance

Revenue Growth (5Y)
12,88%
En dessous de la moyenne du secteur (19,14%)
Revenue (1Y)24,08%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROIC-30,76%
Net Margin-39,85%
Op. Margin-31,50%

Sécurité

Debt / Equity
N/A
Current Ratio1,84
Interest Coverage-3,61

Valorisation

PE (TTM)
-3,61
En dessous de la moyenne du secteur (-0,01)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Services (20 pairs)
Métrique Action Médiane du Secteur
P/E -3,6 0,0
P/B — 3,1
ROE % — -1,5
Net Margin % -39,9 -0,3
Rev Growth 5Y % 12,9 19,1
D/E — 1,0

All Fundamental Metrics
Growth
Revenue Growth (1Y) 24,08% Revenue Growth (3Y) 34,27%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 12,88% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 88,50 M Net Income (TTM) -35,27 M
ROE N/A ROA -39,97%
Gross Margin N/A Operating Margin -31,50%
Net Margin -39,85% Free Cash Flow (TTM) -23,53 M
ROIC -30,76% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1,84
Interest Coverage -3,61 Asset Turnover 1,00
Working Capital 15,25 M Tangible Book Value -21,13 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -3,61 Forward P/E N/A
P/B Ratio N/A P/S Ratio 1,44
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -18,50%
Market Cap 127,17 M Enterprise Value 160,58 M
Per Share
EPS (Diluted TTM) -4,67 Revenue / Share 8,98
FCF / Share -2,39 OCF / Share -2,36
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,29% FCF Conversion 66,72%
SBC-Adj. FCF -28,11 M Growth Momentum 11,20

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 88,50 M 71,32 M 49,09 M 38,21 M 54,51 M
Net Income -35,27 M -42,93 M -52,15 M -65,45 M -43,16 M
EPS (Diluted) -4,67 -0,33 -0,64 -1,55 —
Gross Profit — — — — —
Operating Income -27,87 M -34,50 M -41,34 M -50,59 M -40,94 M
EBITDA — — — — —
R&D Expenses 12,00 M 9,56 M 9,99 M 13,10 M 12,79 M
SG&A Expenses 87,55 M 80,45 M 67,39 M 61,46 M 50,52 M
D&A 5,67 M 5,77 M 3,33 M 3,60 M 3,18 M
Interest Expense 7,72 M 8,26 M 9,54 M 8,07 M 4,51 M
Income Tax 0,0 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 87,48 M 97,24 M 99,10 M 92,91 M 76,10 M
Total Liabilities 89,94 M 76,37 M 94,52 M 72,30 M 56,37 M
Shareholders' Equity -2,47 M 20,88 M 4,58 M 20,61 M 19,73 M
Total Debt 50,01 M 40,03 M 40,08 M 30,13 M 10,08 M
Cash & Equivalents 18,99 M 26,25 M 26,28 M 43,09 M 32,71 M
Current Assets 32,52 M 39,48 M 39,68 M 53,33 M 43,61 M
Current Liabilities 17,44 M 14,32 M 33,42 M 22,84 M 28,96 M